REDCap, the research data management tool created and powered by Vanderbilt University Medical Center, is serving extra duty as research teams and public health authorities around the world grapple with the COVID-19 pandemic. The press of activity is loosely reflected in the results of two automated web searches posted on REDCap’s website: as of June 8, a Google News search for the combined terms “redcap” and “covid” had returned 16,400 items, while a Google Scholar search for these terms had returned 350 research studies and other articles from the scientific literature on COVID.
A few highlights:
- In a study published June 3 in The New England Journal of Medicine, REDCap was used in a randomized controlled trial of hydroxychloroquine for postexposure prophylaxis for COVID-19. The drug was found ineffective.
- Among 92 persons who attended events held at a particular Arkansas church March 6–11, Arkansas Department of Health COVID-19 contract tracing efforts (powered by REDCap) found 35 confirmed cases, an attack rate of 38%. Three patients died.
- Mayo Clinic and the Society of Critical Care Medicine are using REDCap for a global registry of COVID-19 patient data.
- Using REDCap, a team from Australia’s Royal Melbourne Hospital has created a platform for home monitoring of COVID-19 symptoms.
- An international study of COVID-19 in cancer patients, published May 28 in The Lancet, was powered by a REDCap database housed at VUMC.
- A European research consortium is using REDCap to assemble a patient registrydevoted to cardiovascular risks and complications with COVID-19.
- Meharry Medical College is using REDCap to support drive-through testing for COVID-19.
For more information, see How Redcap Is Being Used in Response To COVID-19, on projectredcap.org.
